Podium to Practice: Chicago 2026 – GI: CIRCULATE

Studies / Trials Discussed

LBA3500 – Disease-free survival (DFS) and time to recurrence (TTR) with circulating tumor (ct) DNA–based decision for adjuvant treatment in colon cancer stage II (CIRCULATE): An AIO (KRK-0217)/ABCSG trial.

Explore more from your favourite experts – click their name to access their entire library of content.

Studies/trials discussed:

LBA3500 – Disease-free survival (DFS) and time to recurrence (TTR) with circulating tumor (ct) DNA–based decision for adjuvant treatment in colon cancer stage II (CIRCULATE): An AIO (KRK-0217)/ABCSG trial.